Table 3 Adverse events reported during treatment
| Adverse event | Number (%) |
|---|---|
| No | 16 (76.19%) |
| Dizziness | 1 (4.76%) |
| Anorexia | 1 (4.76%) |
| Sleepiness | 1 (4.76%) |
| Menorrhagia | 1 (4.76%) |
| Sickle cell crisis | 1 (4.76%) |
| Decompensation | 1 (4.76%) |
| Adverse event | Number (%) |
|---|---|
| No | 16 (76.19%) |
| Dizziness | 1 (4.76%) |
| Anorexia | 1 (4.76%) |
| Sleepiness | 1 (4.76%) |
| Menorrhagia | 1 (4.76%) |
| Sickle cell crisis | 1 (4.76%) |
| Decompensation | 1 (4.76%) |